| scholarly article | Q13442814 |
| P50 | author | Eva Feldman | Q5415042 |
| Subramaniam Pennathur | Q87965108 | ||
| Anuradha Vivekanandan-Giri | Q125193959 | ||
| P2093 | author name string | John M Hayes | |
| Andrea M Vincent | |||
| Lisa L McLean | |||
| P2860 | cites work | Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells | Q28171163 |
| Role of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damage | Q28287566 | ||
| Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. | Q33305306 | ||
| High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. | Q51578321 | ||
| High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition. | Q51746503 | ||
| Neurons undergo apoptosis in animal and cell culture models of diabetes. | Q52536719 | ||
| Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress | Q56610055 | ||
| Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice | Q72243308 | ||
| Biosynthesis and post-translational processing of lectin-like oxidized low density lipoprotein receptor-1 (LOX-1). N-linked glycosylation affects cell-surface expression and ligand binding | Q73487438 | ||
| The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM) | Q73676318 | ||
| High density lipoprotein subfractions: isolation, composition, and their duplicitous role in oxidation | Q79302086 | ||
| Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species | Q80157536 | ||
| Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway | Q80838580 | ||
| Criteria for creating and assessing mouse models of diabetic neuropathy | Q33634756 | ||
| Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation | Q34546113 | ||
| Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. | Q34576734 | ||
| The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering? | Q36161631 | ||
| Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. | Q36203941 | ||
| SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy | Q36360471 | ||
| Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. | Q36755721 | ||
| Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. | Q36956727 | ||
| Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice | Q36972748 | ||
| Glucose neurotoxicity | Q37038404 | ||
| Mouse models of diabetic neuropathy | Q37062972 | ||
| Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway | Q37065958 | ||
| The antioxidant response as a drug target in diabetic neuropathy | Q37065975 | ||
| Elevated triglycerides correlate with progression of diabetic neuropathy | Q37236277 | ||
| The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy | Q39452399 | ||
| Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. | Q39903564 | ||
| LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes | Q40005574 | ||
| Lifestyle intervention for pre-diabetic neuropathy | Q40321365 | ||
| Oxidized low-density-lipoprotein accumulation is associated with liver fibrosis in experimental cholestasis. | Q43151995 | ||
| Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis | Q43687605 | ||
| Small fiber neuropathy is associated with the metabolic syndrome | Q44207440 | ||
| Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid | Q44286373 | ||
| Prevention of diet-induced type 2 diabetes in the C57BL/6J mouse model by an antidiabetic herbal formula | Q44296039 | ||
| Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats | Q44530566 | ||
| Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death | Q44779270 | ||
| Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse | Q44815335 | ||
| Vascular dysfunction and autonomic neuropathy in Type 2 diabetes | Q44946392 | ||
| Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes | Q45037409 | ||
| Vascular risk factors and diabetic neuropathy | Q45240267 | ||
| Short-term hyperglycemia produces oxidative damage and apoptosis in neurons | Q45242262 | ||
| Endothelin-converting enzyme-1 increases in atherosclerotic mice: potential role of oxidized low density lipoproteins | Q46255902 | ||
| Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus | Q46405281 | ||
| Reactive carbonyls and polyunsaturated fatty acids produce a hydroxyl radical-like species: a potential pathway for oxidative damage of retinal proteins in diabetes. | Q46458495 | ||
| Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice | Q46505802 | ||
| The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes | Q46596481 | ||
| LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endothelium | Q46662739 | ||
| Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury. | Q46852186 | ||
| Can drug screening lead to candidate therapies for testing in diabetic neuropathy? | Q46931580 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dyslipidemia | Q66291209 |
| P304 | page(s) | 2376-2385 | |
| P577 | publication date | 2009-07-10 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. | |
| P478 | volume | 58 |
| Q30419308 | A high-fat diet delays age-related hearing loss progression in C57BL/6J mice |
| Q37600743 | Absence of clinical relationship between oxidized low density lipoproteins and diabetic peripheral neuropathy: a case control study |
| Q37978264 | Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy |
| Q46443637 | Alterations in peripheral purinergic and muscarinic signaling of rat bladder after long-term fructose-induced metabolic syndrome |
| Q30428077 | Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension |
| Q36501212 | Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy. |
| Q37101622 | Association of comorbidities with increasing severity of peripheral neuropathy in diabetes mellitus |
| Q35558662 | BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses |
| Q26739955 | Bioactive Compounds and Their Neuroprotective Effects in Diabetic Complications |
| Q41665516 | Cardiovascular disease predicts diabetic peripheral polyneuropathy in subjects with type 2 diabetes: A 10-year prospective study. |
| Q93159371 | Chain length of saturated fatty acids regulates mitochondrial trafficking and function in sensory neurons |
| Q37572538 | Chewing the fat: genetic approaches to model dyslipidemia-induced diabetic neuropathy in mice |
| Q84233288 | Current literature in diabetes |
| Q48097245 | Cytokine-mediated inflammation mediates painful neuropathy from metabolic syndrome |
| Q36879268 | Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes |
| Q41618910 | Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy |
| Q35148853 | Detrimental impact of hyperlipidemia on the peripheral nervous system: A novel target of medical epidemiological and fundamental research study |
| Q92733581 | Diabetic neuropathy |
| Q37930962 | Diabetic neuropathy: cellular mechanisms as therapeutic targets |
| Q34275990 | Diabetic neuropathy: clinical manifestations and current treatments |
| Q37375109 | Diabetic neuropathy: mechanisms, emerging treatments, and subtypes |
| Q36293649 | Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? |
| Q92813959 | Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy |
| Q33830497 | Dietary reversal of neuropathy in a murine model of prediabetes and metabolic syndrome. |
| Q41790371 | Dyslipidemia as a contributory factor in etiopathogenesis of diabetic neuropathy |
| Q50114087 | Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons. |
| Q55019616 | Effect of combined dyslipidemia and hyperglycemia on diabetic peripheral neuropathy in alloxan-induced diabetic WBN/Kob rats. |
| Q34487599 | Effect of high-fat diet on peripheral neuropathy in C57BL/6 mice |
| Q39324236 | Effects of acetyl-L-carnitine in diabetic neuropathy and other geriatric disorders. |
| Q42010667 | Effects of melatonin on biochemical factors and food and water consumption in diabetic rats |
| Q38266297 | Efficacy of α-lipoic acid in diabetic neuropathy |
| Q38625575 | Exercise as Therapy for Diabetic and Prediabetic Neuropathy. |
| Q34562889 | Exercise increases cutaneous nerve density in diabetic patients without neuropathy |
| Q23916432 | Frequency-dependent effects of vibration on peripheral nerves and sensory nerve function in a rat model of hand-arm vibration syndrome. (Erratum: Characterization of frequency-dependent responses of the vascular system |
| Q36421364 | Gender-specific differences in diabetic neuropathy in BTBR ob/ob mice |
| Q37550709 | Heat shock protein 70 is necessary to improve mitochondrial bioenergetics and reverse diabetic sensory neuropathy following KU-32 therapy |
| Q27313058 | High energy diets-induced metabolic and prediabetic painful polyneuropathy in rats |
| Q39497436 | High-fat diet and age-dependent effects on enteric glial cell populations of mouse small intestine |
| Q38457192 | High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes |
| Q33781251 | High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L |
| Q42159827 | Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity |
| Q35223053 | Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons |
| Q37659233 | Hyperlipidemia: a new therapeutic target for diabetic neuropathy |
| Q37058951 | Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy |
| Q35219367 | Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitus |
| Q59138107 | Influence of Sex on Cognition and Peripheral Neurovascular Function in Diabetic Mice |
| Q46019226 | Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats. |
| Q91852735 | Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes |
| Q60301081 | Juvenile murine models of prediabetes and type 2 diabetes develop neuropathy |
| Q38911361 | LOX-1-Targeted Iron Oxide Nanoparticles Detect Early Diabetic Nephropathy in db/db Mice |
| Q34423160 | Lectin-like ox-LDL receptor-1 (LOX-1)-Toll-like receptor 4 (TLR4) interaction and autophagy in CATH.a differentiated cells exposed to angiotensin II. |
| Q39132982 | Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy? |
| Q33729719 | Literature-based discovery of diabetes- and ROS-related targets |
| Q33862382 | Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction. |
| Q35535915 | Macrophages in diabetic gastroparesis--the missing link? |
| Q37041169 | Metabolomics in diabetic complications |
| Q42003724 | Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. |
| Q61443044 | Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes |
| Q35911991 | Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathy |
| Q37655239 | Mouse models of diabetic neuropathy |
| Q36007537 | Neurodegeneration and early lethality in superoxide dismutase 2-deficient mice: a comprehensive analysis of the central and peripheral nervous systems |
| Q91893025 | Neuronal LXR Regulates Neuregulin 1 Expression and Sciatic Nerve-Associated Cell Signaling in Western Diet-fed Rodents |
| Q37900473 | Neuropathy in prediabetes: does the clock start ticking early? |
| Q36329924 | Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy |
| Q36012308 | Obesity Takes Its Toll on Visceral Pain: High-Fat Diet Induces Toll-Like Receptor 4-Dependent Visceral Hypersensitivity |
| Q34851871 | PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function |
| Q33623182 | PGC-1α regulation of mitochondrial degeneration in experimental diabetic neuropathy. |
| Q30390555 | PPARalpha: an emerging therapeutic target in diabetic microvascular damage. |
| Q92490864 | Peripheral Neuropathy as a Component of Skeletal Disease in Diabetes |
| Q35579658 | Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice |
| Q38007899 | Prediabetic neuropathy: does it exist? |
| Q37396684 | Protective Effect of Psoralea corylifolia L. Seed Extract against Palmitate-Induced Neuronal Apoptosis in PC12 Cells |
| Q35173711 | Quantitative analysis of amino Acid oxidation markers by tandem mass spectrometry |
| Q38213043 | Recent advances in the management of diabetic distal symmetrical polyneuropathy |
| Q34667363 | Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies |
| Q33677202 | Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in mice |
| Q35733025 | Role of nitrosative and oxidative stress in neuropathy in patients with type 2 diabetes mellitus |
| Q103733283 | Satellite glia as a critical component of diabetic neuropathy: Role of lipocalin-2 and pyruvate dehydrogenase kinase-2 axis in the dorsal root ganglion |
| Q30238727 | Schwann cell interactions with axons and microvessels in diabetic neuropathy |
| Q34747306 | Somatic DNA damages in cardiovascular autonomic neuropathy |
| Q89534387 | Statins and Neuropathic Pain: A Narrative Review |
| Q34944800 | Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients. |
| Q92459188 | The Divergent Roles of Dietary Saturated and Monounsaturated Fatty Acids on Nerve Function in Murine Models of Obesity |
| Q35973863 | The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes. |
| Q26786137 | The balance of powers: Redox regulation of fibrogenic pathways in kidney injury |
| Q35153023 | The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy |
| Q42741514 | The relation of high fat diet, metabolic disturbances and brain oxidative dysfunction: modulation by hydroxy citric acid |
| Q45447599 | The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus |
| Q36714165 | The role of endoplasmic reticulum stress in hippocampal insulin resistance |
| Q37708207 | The role of insulin resistance in diabetic neuropathy in Koreans with type 2 diabetes mellitus: a 6-year follow-up study |
| Q41298557 | The role of oxidative stress in nervous system aging. |
| Q42703766 | Trans-resveratrol attenuates high fatty acid-induced P2X7 receptor expression and IL-6 release in PC12 cells: possible role of P38 MAPK pathway |
| Q35063229 | Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes. |
| Q35854702 | Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress |
| Q61798309 | Verapamil Attenuated Prediabetic Neuropathy in High-Fat Diet-Fed Mice through Inhibiting TXNIP-Mediated Apoptosis and Inflammation |
| Q35723883 | Visualization of Sensory Neurons and Their Projections in an Upper Motor Neuron Reporter Line. |
Search more.